The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in

T Terui1, Y Niitsu, K Mahara

  • 1Department of Internal Medicine (Section 4), Sapporo Medical College, Japan.

Blood
|April 1, 1990
PubMed

Insights

Transforming growth factor-beta (TGF-beta) from megakaryoblasts drives myelofibrosis in acute megakaryoblastic leukemia (AMKBL) by stimulating collagen production in bone marrow fibroblasts.

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Acute myelofibrosis is frequently linked to acute megakaryoblastic leukemia (AMKBL).
  • The precise mechanisms driving myelofibrosis progression in AMKBL remain elusive.
  • Humoral factors from megakaryoblastic cells may enhance collagen synthesis by bone marrow fibroblasts.

Purpose of the Study:

  • To investigate the role of transforming growth factor-beta (TGF-beta) in the myelofibrosis associated with AMKBL.
  • To determine if megakaryoblasts produce and secrete active TGF-beta, stimulating collagen synthesis.

Main Methods:

  • Assessed collagen synthesis in bone marrow fibroblasts using conditioned media from megakaryoblasts and other leukemic cell types.
  • Measured TGF-beta activity via soft agar colony formation.
  • Analyzed TGF-beta mRNA and polypeptide expression in megakaryoblasts using hybridization and antibody detection.
  • Evaluated the effect of anti-TGF-beta antibodies on collagen synthesis.

Main Results:

  • Conditioned media from megakaryoblasts significantly stimulated collagen synthesis in bone marrow fibroblasts.
  • Higher TGF-beta activity was detected in megakaryoblast-conditioned media compared to other leukemic cell types.
  • Megakaryoblasts exhibited greater TGF-beta mRNA expression and polypeptide detection.
  • Anti-TGF-beta antibodies neutralized the collagen synthesis-stimulating effects of megakaryoblast-conditioned media.

Conclusions:

  • Megakaryoblasts produce and secrete active transforming growth factor-beta (TGF-beta).
  • TGF-beta secreted by megakaryoblasts stimulates collagen synthesis in bone marrow fibroblasts.
  • This paracrine mechanism suggests a key role for TGF-beta in AMKBL-associated myelofibrosis.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...